Relation of Mycophenolic Acid Trough Levels and Adverse Events in Kidney Allograft Recipients
- 1 June 1998
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 30 (4) , 1192-1193
- https://doi.org/10.1016/s0041-1345(98)00204-8
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Statistics Notes: Units of analysisBMJ, 1997
- Conversion from cyclosporine A to azathioprine treatment improves LDL oxidation in kidney transplant recipientsKidney International, 1997
- MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1997
- A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1996
- Mycophenolate MofetilDrugs, 1996
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995
- Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejectionThe Lancet, 1995
- Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantationThe Lancet, 1995
- Cutaneous Complications in Immunosuppressed Renal Homograft RecipientsJAMA, 1974